BSCL2 and cyclic hematopoiesis: CH is a feature that is observed in 48 to 61% of the patients with congenital generalized lipodystrophy [40] and has a higher prevalence in patients with seipin mutations (80%) than with AGPAT2 (53%), caveolin 1, and PTRF mutations [48] (Table 3).